Portfolio Tracker
Dein Depot in Echtzeit – Kurse, Renditeanalyse und Dividendenplaner an einem Ort.
Anzeige
CAREDX INC. DL-,001 WKN: A118WG Kürzel: CDNA Forum: Aktien Thema: Hauptdiskussion
70,50
USD
-5,29 % -3,94
01:40:13 Uhr,
UTP Consolidated
Kostenlose Aktienchance per SMS
Ausgewählte Trading-Einschätzungen aufs Handy.
Kommentare 98
Summer.76,
02.08.2022 15:36 Uhr
0
CareDx Launches Personalized AlloHome Patient Monitoring Solution to Augment Pre- and Post-Transplant Care
https://www.businesswire.com/news/home/20220802005596/en/CareDx-Launches-Personalized-AlloHome-Patient-Monitoring-Solution-to-Augment-Pre--and-Post-Transplant-Care
AlloHome Alerts Healthcare Provider of Adverse Events to Drive Earlier Interventions
Summer.76,
02.06.2022 19:15 Uhr
0
https://www.businesswire.com/news/home/20220602005408/en/CareDx-Leads-Transplant-Innovation-with-AiKidney-an-AI-Clinical-Decision-Support-Tool-for-Predicting-Allograft-Rejection-Risk
Summer.76,
24.05.2022 16:24 Uhr
0
https://www.globenewswire.com/news-release/2022/05/24/2449070/31386/en/CareDx-Receives-CE-Mark-for-AlloSeq-HCT-for-Use-in-Hematopoietic-Cell-Transplantation.html
Summer.76,
17.05.2022 16:58 Uhr
0
https://www.globenewswire.com/news-release/2022/05/17/2444754/31386/en/In-CareDx-Initiated-IP-Litigation-Against-Natera-Natera-Now-Drops-1-of-2-Patents-Originally-Asserted-Against-CareDx.html
Summer.76,
06.05.2022 5:55 Uhr
0
CareDx Reports First Quarter 2022 Results
https://www.globenewswire.com/news-release/2022/05/05/2437284/31386/en/CareDx-Reports-First-Quarter-2022-Results.html
Summer.76,
05.05.2022 15:19 Uhr
0
https://www.globenewswire.com/news-release/2022/05/05/2436571/31386/en/CareDx-Validates-Clinical-Performance-of-AlloMap-Kidney-to-Comprehensively-Assess-Transplant-Rejection.html
Summer.76,
14.04.2022 19:42 Uhr
0
https://www.globenewswire.com/news-release/2022/04/14/2422640/31386/en/CareDx-Reports-Over-200-000-Heart-Transplant-Patient-Results-Served.html
CareDx Reports Over 200,000 Heart Transplant Patient Results Served
CareDx Testing Services Have Been Used in Over 30,000 Heart Transplant Patients and Over 90 Percent of Centers in the United States
Summer.76,
11.04.2022 16:12 Uhr
0
https://www.globenewswire.com/news-release/2022/04/11/2419896/31386/en/CareDx-the-Leading-Sponsor-of-UNOS-Transplant-Management-Forum-Demonstrates-the-Value-of-Digital-Solutions-to-Improve-Pre-Transplant-Patient-Referral-and-Waitlisting-Workflow.html
Summer.76,
30.03.2022 17:52 Uhr
0
https://www.globenewswire.com/news-release/2022/03/30/2412689/31386/en/CareDx-Partners-with-the-European-Society-for-Organ-Transplantation-to-Provide-Clinical-Evidence-Supporting-the-Use-of-AlloSeq-cfDNA-with-European-Transplant-Healthcare-Professiona.html
Summer.76,
24.03.2022 20:07 Uhr
0
https://www.globenewswire.com/news-release/2022/03/24/2409242/0/en/CareDx-s-AlloCare-App-Now-Integrated-with-TxAccess-to-Help-Pre-Transplant-Patients-Navigate-the-Waitlist-Process.html
Summer.76,
15.03.2022 9:25 Uhr
0
CareDx Wins $44.9M in Damages in False Advertising Trial Against Natera; ...
https://www.bakersfield.com/ap/news/caredx-wins-44-9m-in-damages-in-false-advertising-trial-against-natera-natera-intentionally/article_8849930e-0d01-591f-b643-3ba8c4035548.html
Summer.76,
03.03.2022 15:13 Uhr
0
CareDx Announces Cibiltech Initiates CIBIL Study Using iBox Artificial Intelligence to Monitor Kidney Transplant Patients
https://www.globenewswire.com/news-release/2022/03/03/2396118/31386/en/CareDx-Announces-Cibiltech-Initiates-CIBIL-Study-Using-iBox-Artificial-Intelligence-to-Monitor-Kidney-Transplant-Patients.html
Results from CareDx’s OKRA Study and Cibiltech’s CIBIL Study will Demonstrate Clinical Utility of iBox for Transplant Patient Management
Summer.76,
02.03.2022 13:40 Uhr
0
https://www.globenewswire.com/news-release/2022/03/02/2395224/31386/en/CareDx-Partners-with-the-National-Kidney-Foundation-to-Advocate-for-Kidney-Transplant-Patients.html
Summer.76,
24.02.2022 22:06 Uhr
0
CareDx Reports Fourth Quarter and Full Year 2021 Results
https://www.streetinsider.com/dr/news.php?id=19673878&gfv=1
Summer.76,
22.02.2022 18:11 Uhr
0
CareDx Leads the Way in Xenotransplant Organ Surveillance in Monitoring World’s First Successful Living Xenotransplantation
https://www.globenewswire.com/news-release/2022/02/22/2389123/31386/en/CareDx-Leads-the-Way-in-Xenotransplant-Organ-Surveillance-in-Monitoring-World-s-First-Successful-Living-Xenotransplantation.html
CareDx’s Innovative, Non-Invasive Blood Tests Are Being Used as a Critical Tool to Help Assess Organ Health
Summer.76,
07.02.2022 15:37 Uhr
0
CareDx Joins Forces with MOTTEP, The National Minority Organ Tissue Transplant Education ...
https://www.bakersfield.com/ap/news/caredx-joins-forces-with-mottep-the-national-minority-organ-tissue-transplant-education/article_155404b3-04ad-5e7e-9d14-9e05ff4e7371.html
Meistdiskutiert
|
|
Thema | ||
|---|---|---|---|
| 1 | NVIDIA Hauptdiskussion | -3,84 % | |
| 2 | DAX Prognose / Germany 40 | -1,98 % | |
| 3 | SERVICENOW Hauptdiskussion | -3,57 % | |
| 4 | Meta Platforms Hauptdiskussion | -4,52 % | |
| 5 | YANDEX Hauptdiskussion | -11,32 % | |
| 6 | RHEINMETALL Hauptdiskussion | -7,85 % | |
| 7 | Ximen Mining Hauptdiskussion | -8,88 % | |
| 8 | Sunrise Energy Metals Hauptdiskussion | -5,16 % | |
| 9 | Mercedes-Benz Group Hauptdiskussion | -1,81 % | |
| 10 | BMW Hauptdiskussion | -3,63 % | Alle Diskussionen |
Aktien
|
|
Thema | ||
|---|---|---|---|
| 1 | NVIDIA Hauptdiskussion | -3,82 % | |
| 2 | SERVICENOW Hauptdiskussion | -3,57 % | |
| 3 | Meta Platforms Hauptdiskussion | -4,55 % | |
| 4 | YANDEX Hauptdiskussion | -11,09 % | |
| 5 | RHEINMETALL Hauptdiskussion | -7,85 % | |
| 6 | Ximen Mining Hauptdiskussion | -8,88 % | |
| 7 | Sunrise Energy Metals Hauptdiskussion | -5,16 % | |
| 8 | Mercedes-Benz Group Hauptdiskussion | -1,81 % | |
| 9 | BMW Hauptdiskussion | -3,63 % | |
| 10 | Renk Group.......der Weg zum Erfolg | -1,84 % | Alle Diskussionen |